Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.Published in
BMC Infect Dis 2020; 20(1):19PMID
31910878ae974a485f413a2113503eed53cd6c53
10.1186/s12879-020-4758-9
Scopus Count
Collections
Related articles
- Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
- Authors: Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN
- Issue date: 2015 Sep
- Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
- Authors: Li D, Hu Y, Werngren J, Mansjö M, Zheng X, Drobniewski F, Hoffner S, Xu B
- Issue date: 2016 Sep
- Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
- Authors: Sengstake S, Bergval IL, Schuitema AR, de Beer JL, Phelan J, de Zwaan R, Clark TG, van Soolingen D, Anthony RM
- Issue date: 2017 Jul 12
- Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
- Authors: Pang Y, Zhu D, Zheng H, Shen J, Hu Y, Liu J, Zhao Y
- Issue date: 2017 Nov 6
- Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
- Authors: Che Y, Bo D, Lin X, Chen T, He T, Lin Y
- Issue date: 2021 Jun 25